New research from the University of Waikato nails down how much light travels from the outside world to babies in the womb, ...

Latigo Biotherapeutics, a non-opioid pain biotech looking to ride the waves created by Vertex Pharmaceuticals' pain drug ...

Age, wellness and health conditions should be looked at, said Dr. Brian Jerusik of Inspira Medical Center Vineland.

At a time when many life sciences companies are shrinking their workforce, Vertex Pharmaceuticals Inc. has once again grown ...

For the next few weeks, the planet Mars will form an isosceles triangle with the two bright stars marking the heads of the ...

From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, ...

A new study shows that the inner core changed shape in just a few decades, challenging previous assumptions and revealing ...

DIA, a global multidisciplinary life sciences membership association, will bring together thousands of stakeholders from all ...

Vertex has entered a reimbursement agreement with NHS England enabling eligible SCD patients to access Casgevy in the public ...

Vertex provided 2025 revenue guidance of $11.75 billion to $12 billion, reflecting 8% growth at the midpoint. Growth is expected from U.S. launches of ALYFTREK and JOURNAVX, along with the continued ...

Our concern this week is that any positive news on inflation will be drowned out by tariff news. As with stocks, future ...

Let’s be honest, the marketing world feels a bit like a whirlwind these days, doesn’t it? Especially in MENA, where rapid digital transformation, evolving consumer behaviour and a growing e-commerce ...